ABSTRACT Broad spectrum antibiotic treatment was given on 21 occasions to 15 patients with bronchiectasis who regularly produced purulent, elastase positive secretions. Although the results showed that sputum clearing-that is, changing from purulent to mucoid-largely depended on the pathogenic organism isolated, this was not exclusively the case and in some cases sputum growing sensitive organisms failed to clear whereas clearing occurred in other samples containing resistant organisms or no obvious pathogens. Clearing of sputum was achieved eventually in 12 of the patients and this was associated with the disappearance of elastase activity, although it returned in 10 patients within one week of stopping treatment. There was no change in sputum elastase where the sputum failed to clear. The clearance of elastase activity was associated with a decrease in protein transudation into the lung secretions. The sputum:serum albumin concentration ratio fell (p < 0.005) from a mean (SD) of 2-32 (1.56) x 10-2 in these 12 patients before treatment to 1*09 (0-40) x 10-2 within the first week of treatment, but rose again to 2-07 (1.29) x 10-2 within one week of stopping treatment. The results suggest that antibiotic treatment when patients are in a stable state may have a beneficial effect on the pathogenic nature of lung secretions and inflammation within the lung.
Elastase activity is frequently a feature of purulent secretions' and it is found regularly in sputum from patients with bronchiectasis2 and cystic fibrosis3 even when they are in a clinically stable state. It has been suggested that this proteolytic activity may be relevant to the pathogenesis of the lung disease since purified neutrophil elastase has been shown to damage ciliated epithelium and reduce ciliary beat frequency in vitro.4
Direct evidence of such effects in vivo is lacking but can be inferred from several related studies.
Firstly, the secretions of patients with bronchiectasis often contain elastolytic activity and this is associated with an increase in protein transudation into the lung from serum, suggesting a degree of bronchial epithelial damage or inflammation even in a stable clinical state.2 Secondly, ciliary activity has been shown to be reduced in patients with bronchiectasis5 and, finally, the bronchial epithelium in such patients shows histological damage.6 The association of these changes with elastase activity Address for reprint requests: Dr RA Stockley, General Hospital, Birmingham B4 6NH. Accepted 3 February 1984 does not necessarily indicate a cause and effect relationship; but such enzyme activity is of potential importance at least in the pathogenesis of progressive lung disease, which occurs in a proportion of such patients.
Previous studies in patients with chronic bronchitis have shown that the presence of elastase activity and a rise in the ratio of sputum to serum albumin are a feature of acute infection rather than the stable clinical state.' Such episodes are associated with a change in sputum from mucoid to purulent, which is usually reversed by antibiotic treatment.
The present study was designed to assess the presence of elastase activity and measure the ratio of sputum to serum albumin in a group of stable outpatients with bronchiectasis who produce purulent sputum regularly. In particular, we were interested to see whether in these relatively symptom free patients changes in the sputum could be induced by broad spectrum antibiotics and to determine whether these might be of potential benefit.
Methods
Twenty one antibiotic studies were carried out in 15 414 outpatients with radiographically proved bronchiectasis. All regularly produced purulent secretions daily and were studied while in a clinical stable state at least six weeks after a recognised exacerbation. Details of the patients are given in table 1. All gave informed consent to participation in the study. Sputum was collected at the start of the study on the first day of antibiotic treatment from waking until the administration of the first dose of antibiotic. Treatment was continued for 14 days and sputum again collected on days 7 and 14. A further sample was collected on day 21, one week after stopping treatment. A portion of the sputum collected (over a four hour period) on days 0, 14, and 21 was sent for routine bacteriological culture. A note was made of the macroscopic appearance (clear or purulent) and the remainder was ultracentrifuged at 50 000 g for 90 min. The supernatant was removed and stored at -70°C; the pellet was discarded. On each occasion during the period of sputum collection 10 ml of venous blood was taken and allowed to clot. The serum was removed after centrifugation and stored at -70°C with subsequent analysis.
Amoxycillin 250 mg three times daily was given initially on an empirical basis in all patients except those who were allergic to penicillin (these two patients were treated initially with co-trimoxazole, two tablets twice daily, or tetracycline, 500 mg four times daily). In patients whose sputum failed to show any response to this treatment the results of the sputum culture were reviewed and a course of the antibiotic indicated or of co-trimoxazole was prescribed at least two weeks later for a further 14 days and the study was repeated.
All sputum samples were analysed for the presence of elastase activity, the elastin agarose diffusion plate being used,9 and the activity was compared with that of a single batch of porcine pancreatic elastase (PPE; British Drug Houses). The results were expressed in Ag porcine pancreatic elastase/ 100 ,ul sample (lower limit of detection 0 8 ,ug/100 ,ul; between batch coefficient of variation 7.5%). The albumin concentration was measured in both the sputum and the corresponding serum sample by rocket immunoelectrophoresis with a monospecific antiserum (Seward Laboratories). The ratio of sputum to serum albumin was calculated and multiplied by 100 for convenience as described previ-
The significance of differences between results for each day of the collection was determined by the Wilcoxon rank sum test for paired data. The values reported are means with standard deviations in parentheses.
Results

ANTIBIOTIC RESPONSE
The bacterial isolates from the initial study in all 15 patients are summarised in table 2. The most prevalent organism isolated was Haemophilus influenzae, which occurred alone in eight of the patients and with Klebsiella sp in a further patient.
During the initial treatment 10 of the patients showed macroscopic clearing of their sputum (change from purulent to clear). Clearing did not depend entirely on the results of the initial sputum culture (table 2). Four patients in whom H infirenzae was isolated failed to respond macroscopically despite receiving a two week course of an appropriate antibiotic. In three of these patients sensitive H injttenzae organisms were still isolated at the end of the treatment (table 2) . Two patients (the sputum 6.51 (3.22) ,ug PPE1100 ,ul and this fell within the first week of treatment to 3*33 (4-71) Ag PPE/100 ,ul. By day 14 four patients were no longer producing sputum and the average value for the remander was 3-01 (3.60) ,ug PPE/100 ul. Within seven days of the end of treatment, however, the average value had risen again to 4-96 (3.28) ,ug PPE/ 100 ,ul. The results are summarised in figure 1. This change was accompanied by a similar fall in the sputum:serum albumin ratio, from an average value of 2-37 (1.52) x 10-2 before treatment to 1-85 (1.47) x 10-2 and 1-94 (1.72) x 10-2 on days 7 and 14 of treatment (n = 21, p < 0-01; n = 17, p < 0-05). Within seven days of the end of treatment, however, the ratio had again risen to 2 13 (1.28) x 10-2.
Closer analysis of individual data showed that it was possible to change the secretions from purulent to mucoid on at least one antibiotic regimen in 12 of the 15 patients. This was associated with a disappearance of elastase activity from the sputum. The individual data are shown in figure 2 with the results from the nine cases in which the sputum did not clear macroscopically and the elastase activity persisted. All except one of the patients whose sputum showed clearing of both purulence and elastase activity did so within the first week of treatment and the elastase activity and purulence returned in all but two figure 3 .
Discussion
Previous studies'-' have suggested that purulent secretions are a source of elastolytic enzymes that are potentially harmful to many of the tissues within the lung." The present data confirm this finding, the initial samples from all our patients containing demonstrable elastase activity even while the patients were clinically stable.
The role of antibiotic treatment in such patients is uncertain. The usual clinical practice is to reserve antibiotic treatment for acute exacerbations of the disease characterised by clinical deterioration, pyrexia, or haemoptysis. Some patients, however, receive long term antibiotic treatment and it has been previously shown'2 that continuous low dose treatment with tetracycline reduced symptoms and sputum volume and improved work record in patients with bronchiectasis. Despite this finding there is currently no evidence that continuous antibiotic treatment affects the long term prognosis of the disease.
The most common infecting organisms isolated from the secretions of bronchiectatic patients are H infiuenzae and Streptococcus pneumoniae. In the present study we isolated these organisms in 11 (73%) of the patients, confirming the propensity of the organisms to colonise the secretions of clinically stable patients with bronchiectasis.
The sputum showed macroscopic clearing in 66-6% of patients treated with a broad spectrum antibiotic regimen known to be usually active in vitro against these organisms. Subsequent change to the antibiotics indicated by culture in the remaining patients led to macroscopic clearing in only two more (13-3%). Although clearing was generally predictable from the initial sputum culture (in eight of the 10 patients who showed clearing with the initial antibiotic regimen) there were exceptions and sputum containing organisms fully sensitive to amoxycillin often failed to show a response. (fig 3) . Within one week of the end of treatment the purulence and elastase activity returned in all but two of the cases and this was associated with an increase in the sputum:serum albumin ratio to the pretreatment level (fig 3) . These results suggest a close association between purulence, elastase activity, and inflammation (as indicated by the sputum:serum albumin ratio). Antibiotic treatment given to these "clinically well" patients can reverse the purulent nature of the secretions, reduce the inflammatory response in the lung, and remove a potentially harmful enzyme. Indeed, recent studies have shown that these secretions have a detrimental effect on ciliary beat frequency in vitro and that this effect can be abolished by antibiotic treatment.'9 Whether such treatment has a similarly beneficial effect in vivo and whether a maintained response can alter progression of the disease remains to be determined.
